kabutan

KYORIN Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 36%, Oct-Dec Ordinary Profit Increases by 2.1 times

Wed Feb 4, 2026 2:00 pm JST Earnings

4569 KYORIN Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

KYORIN Pharmaceutical Co.,Ltd. <4569> [TSE Prime] announced its financial results in the afternoon session on February 4th (14:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded 5.09 billion yen, an increase 35.8% compared to the same period last year. Progress toward the full-year plan of 6.30 billion yen was 80.9%, also surpassing the five-year average of 66.9%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to significant drop 87.3% from the same period last year to 1.20 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.1 times that of the same period last year, reaching 3.51 billion yen. The operating profit margin drastically improved from 4.6% in the same period last year to 9.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 87,267 4,803 5,391 4,149 72.3 79.0 Feb 6, 2024 J-GAAP
Apr - Dec, 2024 89,286 3,115 3,753 2,439 42.5 28.4 Feb 5, 2025 J-GAAP
Apr - Dec, 2025 92,456 4,609 5,097 4,119 71.7 80.9 Feb 4, 2026 J-GAAP
YoY +3.6% +48.0% +35.8% +68.9% +68.9%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 74,948 11,018 11,169 7,831 136.3 37 May 12, 2025 J-GAAP
Oct - Mar, 2025 Guidance 68,269 4,737 4,718 3,306 57.6 37 Nov 7, 2025 J-GAAP
YoY -8.9% -57.0% -57.8% -57.8% -57.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 119,532 6,234 6,822 5,475 95.4 52 May 10, 2024 J-GAAP
Mar, 2025 130,087 12,567 13,219 9,086 158.2 57 May 12, 2025 J-GAAP
Mar, 2026 Guidance 127,000 6,100 6,300 4,800 83.6 57 May 12, 2025 J-GAAP
YoY -2.4% -51.5% -52.3% -47.2% -47.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 34,147 1,566 1,703 1,184 20.6 4.6 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 40,801 9,452 9,466 6,647 115.7 23.2 May 12, 2025 J-GAAP
Apr - Jun, 2025 30,229 2,368 2,624 2,100 36.6 7.8 Jul 31, 2025 J-GAAP
Jul - Sep, 2025 28,502 -1,005 -1,042 -606 -10.6 -3.5 Nov 7, 2025 J-GAAP
Oct - Dec, 2025 33,725 3,246 3,515 2,625 45.7 9.6 Feb 4, 2026 J-GAAP
YoY -1.2% +107.3% +106.4% +121.7% +121.7%

Related Articles